Cipla In Process To Form Alliance With Pfizer
India-based Cipla is currently in talks with Pfizer with an intention to form strategic alliance, reported NDTV. The strategic alliance will focus on the needs of Pfizer in
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.
This grant is based on the successful completion of an earlier Phase I SBIR, and has as a goal the production of commercial products for clinical and research